S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ALLR Allarity Therapeutics Inc

1.08

-0.035 (-3.14%)

After Hours

Last Updated: 17:16:22

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC
Thursday 30 January 2025 (5 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 30 January 2025 (5 days ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 19 November 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Monday 18 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

More Allarity Therapeutics Inc News Articles

Societe Generale Effekten

Solactive leveraged shor...

NLBNPIT1WN33 20991231 6....

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions